Subclinical Thyrotoxicosis and Cardiovascular Risk: Assessment of Circulating Endothelial Progenitor Cells, Proangiogenic Cells, and Endothelial Function

by Jason Phowira, Jason Phowira, Sherin Bakhashab, Anuradha Doddaballapur, Jolanta U. Weaver, Jolanta U. Weaver
Published 2022-07-01

Upregulated miR-18a-5p in Colony Forming Unit-Hill’s in Subclinical Cardiovascular Disease and Metformin Therapy; MERIT Study

by Jason Phowira, Fahad W. Ahmed, Sherin Bakhashab, Jolanta U. Weaver
Published 2022-08-01

MiR-126, IL-7, CXCR1/2 receptors, inflammation and circulating endothelial progenitor cells: The study on targets for treatment pathways in a model of subclinical cardiovascular di...

by David J. Coulson, Sherin Bakhashab, Jevi Septyani Latief, Jolanta U. Weaver
Published 2021-04-01

Upregulation of Anti-Angiogenic miR-106b-3p Correlates Negatively with IGF-1 and Vascular Health Parameters in a Model of Subclinical Cardiovascular Disease: Study with Metformin T...

by Sherin Bakhashab, Josie O’Neill, Rosie Barber, Catherine Arden, Jolanta U. Weaver
Published 2024-01-01

Upregulated anti-angiogenic miR-424-5p in type 1 diabetes (model of subclinical cardiovascular disease) correlates with endothelial progenitor cells, CXCR1/2 and other parameters o...

by Alice Tamara, David J. Coulson, Jevi Septyani Latief, Sherin Bakhashab, Jolanta U. Weaver
Published 2021-05-01

Anti-Angiogenic miR-222, miR-195, and miR-21a Plasma Levels in T1DM Are Improved by Metformin Therapy, Thus Elucidating Its Cardioprotective Effect: The MERIT Study

by Fahad W. Ahmed, Sherin Bakhashab, Inda T. Bastaman, Rachel E. Crossland, Michael Glanville, Jolanta U. Weaver
Published 2018-10-01

Decoding of miR-7-5p in Colony Forming Unit–Hill Colonies as a Biomarker of Subclinical Cardiovascular Disease—A MERIT Study

by Sherin Bakhashab, Hamzah Pratama Megantara, Dimas Kirana Mahaputra, Josie O’Neill, Jason Phowira, Jolanta U. Weaver
Published 2023-07-01

Radioactive Iodine for the Treatment of Subclinical Thyrotoxicosis Grade 1 and 2: Outcome of up to 18-Year Follow Up

by Jason Phowira, Jason Phowira, Katherine L. Coffey, Katherine L. Coffey, Katherine L. Coffey, Peter H. Bartholomew, Peter H. Bartholomew, Nicholas Vennart, Nicholas Vennart, Matheus Moreira, Matheus Moreira, Hannah Emerson, David Kennedy, Jolanta U. Weaver, Jolanta U. Weaver
Published 2022-03-01

Deciphering the Role of miR-200c-3p in Type 1 Diabetes (Subclinical Cardiovascular Disease) and Its Correlation with Inflammation and Vascular Health

by Sherin Bakhashab, Megan Li Yuen Yeoh, David J. Coulson, Samuel Christian Steel, Sabina L. Ray, Jolanta U. Weaver
Published 2022-12-01

Proangiogenic Effect of Metformin in Endothelial Cells Is via Upregulation of VEGFR1/2 and Their Signaling under Hyperglycemia-Hypoxia

by Sherin Bakhashab, Farid Ahmed, Hans-Juergen Schulten, Fahad W. Ahmed, Michael Glanville, Mohammed H. Al-Qahtani, Jolanta U. Weaver
Published 2018-01-01

The Role of miR-342 in Vascular Health. Study in Subclinical Cardiovascular Disease in Mononuclear Cells, Plasma, Inflammatory Cytokines and <i>PANX2</i>

by Sabina L. Ray, David J. Coulson, Megan Li Yuen Yeoh, Alice Tamara, Jevi Septyani Latief, Sherin Bakhashab, Jolanta U. Weaver
Published 2020-09-01

Correction: Linkage Analysis in Autoimmune Addison's Disease: NFATC1 as a Potential Novel Susceptibility Locus.

by Anna L Mitchell, Anette Bøe Wolff, Katie MacArthur, Jolanta U Weaver, Bijay Vaidya, Swedish Addison Registry Study Group, Martina M Erichsen, Rebecca Darlay, Eystein S Husebye, Heather J Cordell, Simon H S Pearce
Published 2015-01-01

Linkage Analysis in Autoimmune Addison's Disease: NFATC1 as a Potential Novel Susceptibility Locus.

by Anna L Mitchell, Anette Bøe Wolff, Katie MacArthur, Jolanta U Weaver, Bijay Vaidya, Swedish Addision Registry Study Group, Sophie Bensing on behalf of The Swedish Addison Registry Study Group, Martina M Erichsen, Rebecca Darlay, Eystein S Husebye, Heather J Cordell, Simon H S Pearce
Published 2015-01-01